Search research articles
Contact Us
Filters
Showing results (11-20 of 481) with videos related to
Page
of 49
Sort By:
Diabetes, Obesity & Metabolism
|
March 13, 2003
Surrogate measures of atherosclerosis and implications for evaluating cardiovascular risk
Nathan D Wong
Expert Review of Cardiovascular Therapy
|
March 3, 2006
Screening and risk stratification of patients with the metabolic syndrome and diabetes
Nathan D Wong
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 19, 2007
Metabolic syndrome: cardiovascular risk assessment and management
Nathan D Wong
Journal of the American College of Cardiology
|
February 28, 2024
Lipoprotein(a): Ready for Prime Time?
Nathan D Wong
Journal of Clinical Medicine
|
August 12, 2022
Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
Nathan D Wong
American Journal of Preventive Cardiology
|
July 30, 2021
Cardiovascular risk assessment: The foundation of preventive cardiology
Nathan D Wong
Canadian Journal of Physiology and Pharmacology
|
June 30, 2022
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks
Nathan D Wong
JACC. Cardiovascular Imaging
|
June 3, 2023
Is a Picture Worth a Thousand Words?
Nathan D Wong
Cardiovascular Endocrinology
|
October 25, 2019
Cardiodiabetology: The convergence of diabetes and cardiovascular disease
Nathan D Wong
Nature Reviews. Cardiology
|
March 26, 2014
Epidemiological studies of CHD and the evolution of preventive cardiology
Nathan D Wong
Page
of 49
Search research articles
Search
Showing results (11-20 of 481) with videos related to
Sort By:
Page
of 49
Diabetes, Obesity & Metabolism
|
March 13, 2003
Surrogate measures of atherosclerosis and implications for evaluating cardiovascular risk
Nathan D Wong
Expert Review of Cardiovascular Therapy
|
March 3, 2006
Screening and risk stratification of patients with the metabolic syndrome and diabetes
Nathan D Wong
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 19, 2007
Metabolic syndrome: cardiovascular risk assessment and management
Nathan D Wong
Journal of the American College of Cardiology
|
February 28, 2024
Lipoprotein(a): Ready for Prime Time?
Nathan D Wong
Journal of Clinical Medicine
|
August 12, 2022
Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
Nathan D Wong
American Journal of Preventive Cardiology
|
July 30, 2021
Cardiovascular risk assessment: The foundation of preventive cardiology
Nathan D Wong
Canadian Journal of Physiology and Pharmacology
|
June 30, 2022
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks
Nathan D Wong
JACC. Cardiovascular Imaging
|
June 3, 2023
Is a Picture Worth a Thousand Words?
Nathan D Wong
Cardiovascular Endocrinology
|
October 25, 2019
Cardiodiabetology: The convergence of diabetes and cardiovascular disease
Nathan D Wong
Nature Reviews. Cardiology
|
March 26, 2014
Epidemiological studies of CHD and the evolution of preventive cardiology
Nathan D Wong
Page
of 49